The Glaucoma Market report provides current treatment practices, emerging drugs, and market share of the individual therapies, current and forecasted 7MM Glaucoma market size from 2018 to 2030. The Report also covers current Glaucoma treatment practice, market drivers, market barriers, SWOT analysis, reimbursement, and market access, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.
Glaucoma Overview
Glaucoma describes a group of conditions in which there is characteristic cupping of the optic disc with corresponding visual field defects, due to retinal ganglion cell loss. It is a progressive condition and the most common cause of irreversible blindness worldwide.
Approach to Free Sample copy @ https://www.delveinsight.com/sample-request/glaucoma-market
Regions Covered
- The United States
- EU5 (Germany, France, Italy, Spain, and the United Kingdom)
- Japan
List of companies involved in the report
- Aerie Pharmaceuticals
- Aerie Pharmaceuticals
- Sun Pharma Advanced Research Company Limited
- Santen Pharmaceutical/Ube Industries
- Bausch and Lomb
- Santen Pharmaceutical Co., Ltd.
- D.Western Therapeutics Institute (DWTI)/Kowa LTD.
- Alcon Research
- Merck Sharp & Dohme Corp.
- Novartis/Alcon Research
- Alcon Research, a Novartis company
- Allergan
- Allergan
- Senju Pharmaceuticals
- Senju Pharmaceuticals
- Sun Pharma Advanced Research Company Limited (SPARC)
- Laboratorios Sophia S.A de C.V.
- Perrigo Company
- Santen Pharmaceutical
- Santen Inc./Ono Pharmaceutical
- Nicox Ophthalmics
- Sylentis
- Envisia Therapeutics
- Ocuphire Pharma
- And many others
Glaucoma Major Categories
The two major categories of glaucoma are open-angle glaucoma (OAG) and narrow-angle glaucoma. Less common types of glaucoma include: Secondary glaucoma, Normal-tension glaucoma, and Pigmentary glaucoma. Of those with glaucoma, the majority (about two-thirds) have the form called open angle glaucoma.
Glaucoma Types
The OAG is primarily divided into two subtypes, i.e., Primary open-angle glaucoma (POAG) and Secondary open-angle glaucoma. POAG is a subset of glaucoma defined by an open, normal-appearing anterior chamber angle and raised intraocular pressure (IOP). In Secondary open-angle glaucoma, there is an identifiable cause of increased eye pressure, resulting in optic nerve damage and vision loss.
Glaucoma Symptoms
The sign and symptoms of Glaucoma differ by subtypes. OAG symptoms includes an increase in IOP, open anterior chamber angle and optic disc changes seen on clinical examination such as high cup to disc ratio, cup to disc ratio asymmetry between eyes, vertical elongation of the cup, etc. while narrow-angle glaucoma symptoms are intense eye pain, headaches or migraines, fuzzy lighting or halo figures, pupil dilation, vision troubles, bloodshot eyes, and physical sickness.
Glaucoma Risk Factors
The risk factors of Glaucoma include older age, family history of glaucoma, African ancestry, nearsightedness, high IOP, low blood pressure, use of topical corticosteroids, inflammation, and tumor.
A Comprehensive Glaucoma diagnostic exam includes examining the inner eye pressure (Tonometry), the shape and color of the optic nerve (Ophthalmoscopy) (dilated eye exam), the complete field of vision (Perimetry (visual field test)), the angle in the eye where the iris meets the cornea (Gonioscopy) and the thickness of the cornea (Pachymetry).
Glaucoma Treatment
The only form of treatment that has been shown to be efficacious and is generally accepted for the prevention of glaucoma progression is reduction of the intraocular pressure. In patients with open-angle glaucoma, the intraocular pressure can be reduced with regularly applied eye drops, laser therapy, and/or surgery.
Glaucoma Market Insights
The main goal of glaucoma treatment is to increase the quality of life through the reduction of IOP to preserve visual function. In the process of IOP reduction, an ideal medication should have a schedule that is simple to follow, be least interrupting with a patient’s life, highly tolerable, and affordable. However, the medical treatment of glaucoma has associated side effects, complications, and costs.
Glaucoma Market Forecast
There are three mainstays for lowering eye pressure, i.e. medication, laser, and surgery. The two types of laser treatments currently used are Selective Laser Trabeculoplasty (SLT) and Argon Laser Trabeculoplasty (ALT). Surgery for Glaucoma includes Cataract Surgery, Micro-Invasive Glaucoma Surgery (MIGS), Trabeculectomy, Drainage Implant Surgery, and Ciliary Body Ablation.
Approach to Free Sample copy @ https://www.delveinsight.com/sample-request/glaucoma-market
Read Detailed Table of Content
1. Key Insights
2. Report Introduction
3. Glaucoma Market Overview at a Glance
4. Executive Summary of Glaucoma
5. Disease Background and Overview
6. Treatment Algorithm for Open-Angle Glaucoma
7. Treatment for Glaucoma
8. Epidemiology and Patient Population
9. Organizations contributing towards Open-Angle Glaucoma (OAG)
10. Patient Journey
11. Case Reports
12. Marketed Products
13. Emerging Therapies
14. Glaucoma: Seven Major Market Analysis
15. KOL Views
16. Market Drivers
17. Market Barriers
18. SWOT Analysis
19. Unmet Needs
20. Reimbursement
21. Appendix
22. DelveInsight Capabilities
23. Disclaimer
24. About DelveInsight
Glaucoma Market Outlook
Glaucoma is an eye disease that gradually steals vision. There are typically no early warning signs or painful symptoms of glaucoma. It develops slowly and sometimes without noticeable sight loss for many years.
The damage caused by glaucoma cannot be reversed. But treatment and regular checkups can help slow or prevent vision loss, especially if the disease is in its early stages. Glaucoma is treated by lowering the eye pressure (intraocular pressure). Depending on the situation, the options may include prescription eye drops, oral medications, laser treatment, surgery or a combination of any of these.
Glaucoma Market Report Highlights
- The robust pipeline with novel MOA and oral ROA, increasing prevalence, effectiveness of drugs as both mono and combination therapy will positively drive the Glaucoma market.
- The companies and academics are working to assess challenges and seek opportunities that could influence Glaucoma R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition.
- Major players are involved in developing therapies for Glaucoma. The launch of emerging therapies will significantly impact the Glaucoma market.
- Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities.
Why should you buy this report?
- The report will help in developing business strategies by understanding trends shaping and driving Glaucoma.
- To understand the future market competition in the Glaucoma market and Insightful review of the key market drivers and barriers.
- Organize sales and marketing efforts by identifying the best opportunities for Glaucoma in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
- Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors.
- Organize sales and marketing efforts by identifying the best opportunities for the Glaucoma market.
- To understand the future market competition in the Glaucoma market.
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Contact Us
Shruti Thakur
info@delveinsight.com
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/